Sign Out
Hypersensitivity to felodipine or any component of the product.
History of previous allergic reaction to other dihydropyridine calcium channel blockers because of theoretical risk of cross-reactivity.
Clinically significant aortic stenosis.
Uncompensated heart failure.
Acute myocardial infarction.
Unstable angina pectoris.
As with other calcium channel blockers, felodipine should be discontinued in patients who develop cardiogenic shock.
Pregnancy.
